Patents expiring in 2031

US 8084431

Method for inhibiting activation of macrophages, inhibiting formation of osteoclasts, inhibiting function of osteoclasts, and/or activating osteoblasts

China Medical University · Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8084572

Segmented polymers and their conjugates

Nektar Therapeutics · Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8084498

Ketone compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8084095

Ceramic/structural protein composites and method of preparation thereof

UNIVERSITY OF CONNECTICUT · Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8084248

Reverse genetic system for rift valley fever virus and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8084415

Uteroglobin in the treatment of IGA mediated nephropathy

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8084234

Isolated nucleic acid molecules encoding a fusion protein capable of binding VEGF

REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8084058

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Takeda Pharmaceutical Company Limited · Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8084417

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. · Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8084016

Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products

The Regents of the University of California · Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8084018

Methods for imaging dopamine transporter level

Alseres Pharmaceuticals, Inc. · Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8084015

Stabilized synthetic immunogen delivery system

United Biomedical, Inc. · Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2399593

Semuloparin zur Prävention eines Mortalitäts- und/oder Morbiditätsereignisses bei einem Patienten, an dem ein schwerer chirurgischer Eingriff vorgenommen wird

AVENTIS PHARMA SA [FR] · Granted Wed Dec 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Dec 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2399591

Semuloparin zur Prävention eines Mortalitäts- und/oder Morbiditätsereignisses bei einem Patienten, an dem ein schwerer chirurgischer Eingriff vorgenommen wird

AVENTIS PHARMA SA [FR] · Granted Wed Dec 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Dec 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2399590

Semuloparin zur Prävention eines Mortalitäts- und/oder Morbiditätsereignisses bei einem Patienten, an dem ein schwerer chirurgischer Eingriff vorgenommen wird

AVENTIS PHARMA SA [FR] · Granted Wed Dec 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Dec 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2399592

Semuloparin zur Prävention eines Mortalitäts- und/oder Morbiditätsereignisses bei einem Patienten, an dem ein schwerer chirurgischer Eingriff vorgenommen wird

AVENTIS PHARMA SA [FR] · Granted Wed Dec 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Dec 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2011162951

COMPOSITIONS ET PROCÉDÉS D'AMÉLIORATION DE LA RÉDUCTION D'UN MICRO-ORGANISME SPOROGÈNE

BAUSCH & LOMB [US] · Granted Thu Dec 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088388

Stabilized synthetic immunogen delivery system

United Biomedical, Inc. · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088749

Compositions and methods for treating cancer

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088774

Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death

Northwestern University · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088787

Methods related to the treatment of neurodegenerative and inflammatory conditions

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088760

Benzoxazole carboxamide inhibitors of poly(ADP-ribose)polymerase (PARP)

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088821

Fused cyclic compounds

Takeda Pharmaceutical Company Limited · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088894

Methods and compositions for Mycoplasma pneumoniae exotoxins

The Board of Regents of the University of Texas System · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088884

Multi-armed forms of activated polyoxazoline and methods of synthesis thereof

Serina Therapeutics, Inc. · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088809

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Jenrin Discovery, LLC · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088908

Humanized anti-prostate stem cell antigen monoclonal antibody

The Regents of the University of California · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088931

Small molecule inhibitors of MDM2 and the uses thereof

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088935

Compounds and methods for the treatment of asthma

IRONWOOD PHARMACEUTICALS, INC. · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088759

1,4-benzodiazepine-2,5-diones with therapeutic properties

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088926

Substituted 2-methyl-2-phenoxy-N-propyl-propionamides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity

Jenrin Discovery, LLC · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088798

Cannabinoid receptor antagonists/inverse agonists useful for treating obesity

Jensen Discovery, Inc. · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088729

Anti-viral griffithsin compounds, compositions and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088604

Production of defined monodisperse heparosan polymers and unnatural polymers with polysaccharide synthases

The Board of Regents of the University of Oklahoma · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088365

Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution

Nektar Therapeutics · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088379

Modified T cell receptors and related materials and methods

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8088726

Process for producing sustained-release composition

Takeda Pharmaceutical Company Limited · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2012003230

SUSTAINED RELEASE DRUG DELIVERY SYSTEMS COMPRISING A WATER SOLUBLE THERAPEUTIC AGENT AND A RELEASE MODIFIER

TROGDEN JOHN T [US] · Granted Thu Jan 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)